# AXTLE

NDC: 83831-131
Generic name: pemetrexed
Labeler / Manufacturer: Avyxa Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250101

FDA application: NDA210661

## Active ingredients

- PEMETREXED: 100 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83831-131"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83831-131
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9582c46c-d8b0-44b7-a2ee-9c86f5e9b7b1